Professor Naomi Allen
BSc, MSc, DPhil
Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is a Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She joined UK Biobank as Senior Epidemiologist in 2011, and became Chief Scientist in 2019, where she is responsible for following-up participants both through linkage with routine health-related datasets, and through web-based questionnaires. She is also involved in developing the scientific strategy for future enhancements for the study. Her research interest is largely in the role of diet, obesity and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world.
Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank.
Armstrong J. et al, (2020), Microb Genom
Haematological markers and prostate cancer risk: a prospective analysis in UK Biobank.
Watts EL. et al, (2020), Cancer Epidemiol Biomarkers Prev
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions.
Littlejohns TJ. et al, (2020), Nat Commun, 11
Body size, body composition and endometrial cancer risk among postmenopausal women in UK Biobank.
Omiyale W. et al, (2020), Int J Cancer
Microbial isolation in English participants in the UK Biobank cohort: comparison with the general population
Hilton B. et al, (2020)